Classic psychedelic drugs include LSD, psilocybin and mescaline. This new School of Public Health research is published in the Journal of Psychopharmacology.
During the past few years, technological innovations have opened up an entirely new way to approach scientific questions. Data-driven research starts with massive information sets — the genomic profiles of thousands of patients, for example, or millions of spam emails — and then searches for emerging patterns in that data. In the latest issue of the U.S. Chamber of Commerce’s "Business Horizon Quarterly", UAB President Ray Watts, M.D., explains the way data-driven research at UAB is being applied to find novel treatments for disease, create new products and businesses and train the next generation of innovation-savvy students.
editing the brain
Epigenetic changes are implicated in a host of neural conditions, from Alzheimer's-related memory loss to depression. Now, a revolutionary set of molecular editing tools are allowing scientists to alter the epigenome like never before. In The Mix, UAB neuroscientist Jeremy Day, Ph.D., explains how he uses these techniques in his lab, and why they could lead to an entirely new kind of therapy.
New strategies for acquiring objective data are in their infancy, and support for better tools is needed, say experts in the International Journal of Obesity.
Roadmap of early differentiation genes points to key role for dmrt1 in how the egg incubation temperature determines the sex of a hatchling.
Neuroradiologist Robert Kessler, M.D., is using UAB’s powerful cyclotron to develop imaging tests that reveal changes caused by depression, addiction, Parkinson’s disease and more.
HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.
mix scansNeurologist Hassan Fathallah-Shaykh, M.D., Ph.D., is deploying a new weapon in the war on cancer: mathematical theory. His sophisticated models of tumor growth are predicting new insights on cancer behavior — and could eventually guide treatment decisions.
Best of 2014 2Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy.
Mohammad Khaled, Ph.D., professor emeritus in the Department of Nutrition Sciences, was awarded a Fulbright-Nehru Academic and Professional Excellence Award to develop and improve research and teaching efforts in India related to Type 2 diabetes mellitus.
A one-year, 20 percent increase in research grants elevates UAB to No. 10 among public universities receiving National Institutes of Health funding.
Sergey Mirov, UAB’s fifth NAI fellow, creates novel lasers and finds new applications for them.
A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.
A new UAB study reports on a potential new treatment for frontotemporal dementia, the second most common type after Alzheimer’s disease.

New International Journal of Obesity paper offers an algorithm to more accurately predict body weight change outcomes.

A UAB study of hospital deaths during childbirth suggests the high death rate of African-American women is likely associated with access to prenatal care.

A UAB School of Public Health researcher has published a theory that suggests a mother’s activity and metabolism can influence her child’s likelihood of being obese.

The multi-project research targets key molecular steps of immune cell-fate decisions after virus infection.
Research revealing new evidence about the role of the spleen following heart attack will be honored during the AHA scientific meeting Nov. 15-19.
UAB researchers compared two sets of guidelines to ascertain if people with chronic kidney disease should take statins to reduce high cholesterol levels linked to cardiovascular disease.
Page 9 of 56
Back to Top